Avalo Therapeutics, Inc. - Common Stock (NQ:AVTX)
Price and Volume
Detailed Quote| Volume | 145,063 |
| Open | 18.98 |
| Bid (Size) | 19.01 (500) |
| Ask (Size) | 19.37 (100) |
| Prev. Close | 18.91 |
| Today's Range | 18.75 - 19.60 |
| 52wk Range | 3.390 - 20.72 |
| Shares Outstanding | 96,008,951 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Wondering what's happening in today's pre-market session? ↗
September 29, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
September 29, 2025
Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors
September 22, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
August 01, 2025
Avalo Therapeutics to Participate in Upcoming Investor Conferences
February 24, 2025
Frequently Asked Questions
Is Avalo Therapeutics, Inc. - Common Stock publicly traded?
Yes, Avalo Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Avalo Therapeutics, Inc. - Common Stock trade on?
Avalo Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Avalo Therapeutics, Inc. - Common Stock?
The ticker symbol for Avalo Therapeutics, Inc. - Common Stock is AVTX on the Nasdaq Stock Market
What is the current price of Avalo Therapeutics, Inc. - Common Stock?
The current price of Avalo Therapeutics, Inc. - Common Stock is 19.21
When was Avalo Therapeutics, Inc. - Common Stock last traded?
The last trade of Avalo Therapeutics, Inc. - Common Stock was at 12/19/25 01:27 PM ET
What is the market capitalization of Avalo Therapeutics, Inc. - Common Stock?
The market capitalization of Avalo Therapeutics, Inc. - Common Stock is 1.84B
How many shares of Avalo Therapeutics, Inc. - Common Stock are outstanding?
Avalo Therapeutics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.